High-dose methotrexate for patients with osteosarcoma in resource-poor settings
BACKGROUND: Methotrexate (MTX) is one of the most widely used antifolate analogs. It is active against both hematological and solid tumors. Healthcare providers are reluctant to use high-dose MTX (HDMTX) on patients in various institutions, especially in resource-poor settings. Not much data are ava...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2026-07-01
|
| Schriftenreihe: | Annals of Oncology Research and Therapy |
| Schlagworte: | |
| Online-Zugang: | https://journals.lww.com/10.4103/aort.aort_39_25 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|